The immune-suppressive environment, supported by myeloid-derived suppressor cells (MDSCs) and cytokines such as IL-10, further limits the efficacy of immune checkpoint inhibitors, sustaining tumor survival [48,49,51]. The gene discussed is IL10; the disease is neoplasm.